Meridian Bioscience Inc (VIVO) - Medical Equipment - Deals and Alliances Profile
October 2018
61
About the Report
About the Report
Summary
Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.
Meridian Bioscience Inc (VIVO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Meridian Bioscience Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Meridian Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Meridian Bioscience Inc, Medical Equipment, Deal Details 11
Private Equity 11
Telegraph Hill Partners Acquires Dynex Technologies 11
Partnerships 12
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 12
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 13
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 14
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 15
Biohit Enters Into Distribution Agreement With Dynex Technologies 16
Equity Offering 17
Meridian Bioscience Plans to Raise USD100 Million in Public Offering of Securities 17
Acquisition 18
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 18
Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics 20
Meridian Bioscience Inc-Key Competitors 21
Meridian Bioscience Inc-Key Employees 22
Meridian Bioscience Inc-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Strategy And Business Planning 25
Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 25
Financial Announcements 26
Jul 31, 2018: Meridian Bioscience reports third quarter 2018 operating results, declares regular third quarter cash dividend, and reaffirms fiscal 2018 guidance 26
Apr 26, 2018: Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance 28
Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of USD 52.3 Million In Q1 fiscal 2018 30
Nov 09, 2017: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance 33
Oct 19, 2017: Meridian Bioscience Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings Guidance 35
Jul 27, 2017: Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results 37
Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results 40
Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance 42
Jan 25, 2017: Meridian Bioscience Reports First Quarter 2017 Operating Results, Reduces Regular Cash Dividend, and Revises Fiscal 2017 Guidance Downward 44
Corporate Communications 46
Sep 24, 2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors 46
Oct 10, 2017: Meridian Bioscience Appoints Jack Kenny as Chief Executive Officer 47
Aug 08, 2017: Meridian Bioscience Elects John Rice to the Board of Directors 48
Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 49
May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire 50
Legal and Regulatory 51
Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics 51
Jul 13, 2017: Meridian Bioscience Comments on Recent FDA Press Statement 52
Government and Public Interest 53
Jun 06, 2017: Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics 53
Product News 54
Aug 02, 2017: Bioline Launches New JetSeq Clean Kit for Next-Generation Sequencing 54
Mar 27, 2017: Bioline Launches New JetSeq DNA Quantification Kits 55
Feb 08, 2017: Bioline Launches New JetSeq DNA Library Preparation Kits 56
Feb 03, 2017: Meridian Bioscience Announces the Launch of TruQuick Rapid Tests for Asia Pacific 57
Jan 09, 2017: Bioline Launches the Full Range of EPIK miRNA Assays 58
Other Significant Developments 59
Mar 21, 2018: Meridian Bioscience Realigns Organizational Structure 59
Jun 30, 2017: Meridian Bioscience Comments on Recent FDA Matters Related to Magellan Diagnostics 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61
List of Figure
List of Figures
Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Meridian Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Table
List of Tables
Meridian Bioscience Inc, Medical Equipment, Key Facts, 2017 2
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Meridian Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Meridian Bioscience Inc, Deals By Market, 2012 to YTD 2018 9
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Telegraph Hill Partners Acquires Dynex Technologies 11
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 12
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 13
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 14
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 15
Biohit Enters Into Distribution Agreement With Dynex Technologies 16
Meridian Bioscience Plans to Raise USD100 Million in Public Offering of Securities 17
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 18
Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics 20
Meridian Bioscience Inc, Key Competitors 21
Meridian Bioscience Inc, Key Employees 22
Meridian Bioscience Inc, Subsidiaries 23
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.